Swiss Startup Momm Diagnostics Aims to Launch Point-of-Care Preeclampsia Test in 2024
Momm Diagnostics is currently benchmarking its offering against other tests for preeclampsia, while courting investors to support a new phase of development.
Source: 360dx.com